VOQUEZNA met its primary endpoint in its Phase 3 pivotal trial by demonstrating a significant and rapid reduction of heartburn with daily treatment VOQUEZNA represents the first major innovation in ...

An orally disintegrating tablet (ODT) formulation that can be taken without water has been newly added to Ja Q Bo (ingredient name: zastaprazan), the 37th domestically developed new drug for ...

June 6 (Reuters) - Generic drugmaker Perrigo Co. said a federal court ruled in its favor in patent litigation involving its over-the-counter Famotidine tablets used for treatment of heartburn due to ...

VOQUEZNA, the first and only FDA-approved potassium-competitive acid blocker (PCAB), is now available through major retail pharmacies and BlinkRx, an end-to-end digital fulfillment channel VOQUEZNA ...

This leaflet answers some common questions about SALPRAZ HEARTBURN RELIEF. It does not contain all the available information. It does not take the place of talking to your pharmacist or doctor. The ...

U.S. health regulators are telling drugmakers to immediately pull their popular heartburn drugs off the market after determining that a contamination issue with the medications poses a greater risk ...

Omeprazole ranks amongst the most frequently prescribed medications in the UK. The latest figures reveal that 73 million NHS prescriptions for proton pump inhibitors (PPIs), such as Omeprazole, were ...

FLORHAM PARK, N.J., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for ...

Erosive GERD approval provides Phathom $175 million under its revenue interest financing agreement Conference call and webcast scheduled for November 2, 2023, at 11:00 a.m. ET FLORHAM PARK, N.J., Nov.